Pacer Advisors, Inc. Fibrogen Inc Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$18.57 - $35.68 $41,039 - $78,852	-2,210 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$31.0 - $55.72 $31,558 - $56,722	-1,018 Reduced 31.54%	2,210 $77,000
Q4 2020 Jan 20, 2021	BUY	$37.09 - $48.97 $17,654 - $23,309	476 Added 17.3%	3,228 $120,000
Q3 2020 Oct 19, 2020	BUY	$40.47 - $45.5 $111,373 - $125,216	2,752 New	2,752 $113,000
Q4 2018 Feb 13, 2019	SELL	$37.97 - $60.16 $153,474 - $243,166	-4,042 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $227,564 - $271,824	4,042 New	4,042 $246,000
Q1 2018 May 14, 2018	SELL	$45.35 - $61.65 $43,082 - $58,567	-950 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $457,632 - $655,630	-10,909 Reduced 91.99%	950 $45,000
Q3 2017 Nov 08, 2017	BUY	$33.4 - $53.9 $396,090 - $639,200	11,859	11,859 $638,000

46.8M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $45M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.